Procter & Gamble (PG) Insider Files Form 144 for 7,230 Shares

Rhea-AI Filing Summary

Procter & Gamble Company (PG) Form 144 notice reports a proposed sale of 7,230 shares of common stock through Morgan Stanley Smith Barney LLC on 08/19/2025 with an aggregate market value of $1,119,963.15. The shares were acquired the prior day, 08/18/2025, as a Performance Stock Program Award from The Procter & Gamble Company and payment was recorded on 08/18/2025. The filing lists total shares outstanding as 2,342,371,488. The filer certifies no undisclosed material adverse information and provides signature and legal attestations required by the form.

Insights

Financial Analyst

TL;DR: Routine insider sale of recently awarded shares; size is immaterial relative to outstanding shares.

The Form 144 documents a planned sale of 7,230 shares valued at $1.12M executed through a major broker. Given the reported 2.34 billion shares outstanding, this disposal represents a de minimis portion of the float. The shares were received as a performance award one day prior to the proposed sale, and the filer affirms absence of undisclosed material information. From a market-impact perspective, this filing appears procedural and unlikely to affect PG's valuation materially.

Corporate Governance Expert

TL;DR: Filing meets Rule 144 disclosure mechanics; timing indicates sale of newly vested award.

The notice supplies the required mechanics: broker identity, acquisition date, nature of acquisition (performance stock award), sale date, and aggregate value. The immediate sale after award vesting is permissible under Rule 144 if holding and other conditions are satisfied; the filer also attests to no undisclosed material information. This is a routine disclosure from a governance and compliance standpoint rather than a material corporate event.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 38th Floor New York NY 10004	7230	1119963.15	2342371488	08/19/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	08/18/2025	Performance Stock Program Award	The Procter & Gamble Company			15704	08/18/2025	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What shares does the PG Form 144 report?

The filing reports a proposed sale of 7,230 shares of Procter & Gamble common stock.

When and through whom is the sale scheduled?

The sale is listed for 08/19/2025 through Morgan Stanley Smith Barney LLC (NYSE broker).

How were the shares acquired?

The shares were acquired on 08/18/2025 as a Performance Stock Program Award from The Procter & Gamble Company.

What is the aggregate market value reported?

Aggregate market value is reported as $1,119,963.15.

How many Procter & Gamble shares are outstanding per the filing?

The filing lists 2,342,371,488 shares outstanding.